Myeloid cells in hepatocellular carcinoma

Area of Science:

• Oncology
• Immunology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is strongly linked to chronic inflammation.
• Myeloid cells, such as tumor-associated macrophages and myeloid-derived suppressor cells, infiltrate the HCC tumor microenvironment.
• These myeloid cells are frequently correlated with unfavorable patient prognoses in HCC.

Purpose of the Study:

• To review the multifaceted roles of myeloid cells within the hepatocellular carcinoma microenvironment.
• To highlight the immune-suppressive and tumor-promoting functions of these cells in HCC.
• To discuss the implications of myeloid cell activity for developing novel HCC therapies.

Main Methods:

• Literature review and synthesis of existing research on myeloid cells in HCC.
• Analysis of the functional impact of myeloid cells on tumor initiation, progression, angiogenesis, and metastasis.
• Examination of myeloid cell contributions to therapeutic resistance in HCC.

Main Results:

• Myeloid cells are key drivers of HCC pathogenesis, supporting tumor growth and spread.
• These cells actively suppress anti-tumor immune responses within the HCC microenvironment.
• Myeloid cell functions directly contribute to resistance against current HCC treatments.

Conclusions:

• Myeloid cells orchestrate critical pro-tumorigenic and immunosuppressive activities in HCC.
• Targeting myeloid cell functions presents a promising avenue for innovative HCC therapeutic strategies.
• Further research into myeloid cell biology is essential for advancing HCC treatment outcomes.